Seelos Therapeutics Inc. (SEEL) Upgraded Issued by Wall Street Gurus – News Heater
Home  »  Business   »  Seelos Therapeutics Inc. (SEEL) Upgraded Issued by...

Seelos Therapeutics Inc. (SEEL) Upgraded Issued by Wall Street Gurus

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Seelos Therapeutics Inc. (NASDAQ:SEEL) went up by 0.89% from its latest closing price compared to the recent 1-year high of $6.60. The company’s stock price has collected -3.00% of loss in the last five trading sessions. Press Release reported on 10/01/21 that Seelos Therapeutics to Present a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research

Is It Worth Investing in Seelos Therapeutics Inc. (NASDAQ :SEEL) Right Now?

Plus, the 36-month beta value for SEEL is at 2.82. Opinions of the stock are interesting as 6 analysts out of 6 who provided ratings for Seelos Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The average price from analysts is $9.50. SEEL currently public float of 97.31M and currently shorts hold a 3.91% ratio of that float. Today, the average trading volume of SEEL was 3.10M shares.

SEEL’s Market Performance

SEEL stocks went down by -3.00% for the week, with a monthly jump of 16.49% and a quarterly performance of -5.04%, while its annual performance rate touched 146.67%. The volatility ratio for the week stands at 5.52% while the volatility levels for the past 30 days are set at 9.77% for Seelos Therapeutics Inc.. The simple moving average for the period of the last 20 days is 2.56% for SEEL stocks with a simple moving average of -27.36% for the last 200 days.

Analysts’ Opinion of SEEL

Many brokerage firms have already submitted their reports for SEEL stocks, with ROTH Capital repeating the rating for SEEL by listing it as a “Buy.” The predicted price for SEEL in the upcoming period, according to ROTH Capital is $8 based on the research report published on September 27th of the current year 2021.

Guggenheim, on the other hand, stated in their research note that they expect to see SEEL reach a price target of $8. The rating they have provided for SEEL stocks is “Buy” according to the report published on July 01st, 2021.

Cantor Fitzgerald gave a rating of “Overweight” to SEEL, setting the target price at $10 in the report published on June 01st of the current year.

SEEL Trading at 6.15% from the 50-Day Moving Average

After a stumble in the market that brought SEEL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.76% of loss for the given period.

Volatility was left at 9.77%, however, over the last 30 days, the volatility rate increased by 5.52%, as shares surge +20.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.73% upper at present.

During the last 5 trading sessions, SEEL fell by -3.00%, which changed the moving average for the period of 200-days by +31.40% in comparison to the 20-day moving average, which settled at $2.22. In addition, Seelos Therapeutics Inc. saw 43.04% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for SEEL

The total capital return value is set at -305.30, while invested capital returns managed to touch -387.52. Equity return is now at value -132.00, with -96.90 for asset returns.

Based on Seelos Therapeutics Inc. (SEEL), the company’s capital structure generated 378.07 points at debt to equity in total, while total debt to capital is 79.08. Total debt to assets is 55.58, with long-term debt to equity ratio resting at 283.55. Finally, the long-term debt to capital ratio is 59.31.

>> 7 Top Picks for the Post-Pandemic Economy <<

The liquidity ratio also appears to be rather interesting for investors as it stands at 2.35.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam